International Journal of Antimicrobial Agents
Volume 25, Issue 5 , Pages 404-408 , May 2005

Antimicrobial and healing activity of kefir and kefiran extract

Received 27 May 2004 ,Accepted 17 September 2004.

References 

  1. Nichols RL. Preventing surgical site infections. A surgeon's perspective. Emerg Infect Dis. 2001;7:220–224
  2. Martínez JL, Baquero F. Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity and antibiotic resistance. Clin Microbiol Rev. 2002;15:647–679
  3. Hoellman DB, Kelly LM, Jacobs MR, et al. In vitro anti-anaerobic activity of the cephalosporin derivative RWJ 54428, compared to seven other compounds. Clin Microb Infect. 2002;8:814–822
  4. Yau YH, Ho B, Tan NS, et al. High therapeutic index of factor C sushi peptides: potent antimicrobials against P. aeruginosa. Antimicrob Agents Chemother. 2001;45:2820–2825
  5. Cooper RA, Molan PC, Harding KG. The sensitivity to honey of Gram-positive cocci of clinical significance isolated from wounds. J. Appl. Microbiol. 2002;93:857–863
  6. Cardoso CC, Macêdo SB, Carvalho JCT, et al. Azione dell’olio ozonizzato (Bioperoxoil®) nelle lesione chirurgiche dei modelli pre-clinici. Farm Terap. 2002;19:56–60
  7. Reid G. Probiotic agents to protect the urogenital tract against infection. Am J Clin Nutr. 2001;72:437S–443S
  8. Simova E, Beshkova D, Angelov A, et al. Lactic acid bacteria and yeasts in kefir grains and kefir made from them. J Ind Microb Biotechnol. 2002;28:1–6
  9. Micheli L, Uccelletti D, Palleschi C, et al. Isolation and characterisation of a ropy lactobacillus strain producing the exopolysaccharide quefiran. Appl Microb Biotech. 1999;53:69–74
  10. Schneedorf JM, Anfiteatro D. O quefir e inflamação. In: Carvalho JCT, editor. Fitoterápicos anti-inflamatórios: aspectos químicos, farmacológicos e aplicações terapêuticas. São Paulo: Tecmedd; 2004.
  11. Performance standards for antimicrobial disk susceptibility test: approved standard M2-A6. 6th ed. Wayne, PA: National Committee for Clinical Laboratory Standards (NCCLS); 2002.
  12. Speroni E, Govoni P, Guizzard S, et al. Anti-inflammatory and cicatrizing activity of Echinacea pallida Nutt. root extract. J Ethnopharm. 2002;79:265–272
  13. Roos NM, Katan MB. Effects of probiotic bacteria on diarrhea, lipid metabolism, and carcinogenesis. A review of papers published between 1988 and 1998. Am J Clin Nutr. 2000;71:405–411
  14. Sullivan A, Nord CE. Probiotics in human infections. J Antimicrob Chemother. 2002;50:625–627
  15. Matijasik BB, Rogelsj I. Lactobacillus K7—a probiotic strain. Food Technol Biotechnol. 2000;38:113–121
  16. Kumthavee N. Action of bacteriocin from Lactobacillus casei spp. Rhamnosus (SN11) against pathogenic bacteria. In: Proceedings of the 12th Annual Meetingof the Thai Society for Biotechnology. Kanchanaburi, Thailand, 1–3 November. 2000;
  17. Padilla C, Lobos O, Brevis P, et al. In vitro antibacterial activity of the peptide PsVP-10 against antimicrobial-resistant Enterococcus faecalis isolated from clinical samples. J Animicrob Chemother. 2004;53:390–392
  18. Frengova GI, Simova ED, Beshkova DM, et al. Exopolysaccharides produced by lactic acid bacteria of kefir grains. Zeitsch Natur. 2002;57:805–810
  19. Pinchuk IV, Bressollier P, Verneuil B, et al. In vitro anti-Helicobactecter pylori activity of the probiotic strain Bacillus subtilis 3 is due to secretion of antibiotics. Antimicrob Agents Chemother. 2001;45:3156–3161
  20. Medeiros AC, Ramos AM, Filho AMD, et al. Tratamento tópico de queimaduras do dorso de ratos com ácido hialurônico. Acta Cir Bras. 1999;14:1–7

PII: S0924-8579(05)00054-3

doi: 10.1016/j.ijantimicag.2004.09.020

International Journal of Antimicrobial Agents
Volume 25, Issue 5 , Pages 404-408 , May 2005